{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:52:53Z","timestamp":1794009173386,"version":"4.8.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The effect of concurrent diabetes on the outcome of sepsis is not conclusively known. A meta-analysis published in 2017 indicated that diabetes did not influence the mortality of patients with sepsis but increased the risk of acute renal injury. In view of publication of several new studies in recent years, there is a need for updated evidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic search was conducted using the PubMed, Scopus, Embase, and Google Scholar databases. Studies that were done in patients with sepsis, were observational in design- either cohort or case\u2013control or analysed retrospective data were considered for inclusion. Statistical analysis was performed using STATA software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 21 studies were included. The risk of in-hospital mortality (RR 0.98, 95% CI 0.93, 1.04) and mortality at latest follow up i.e., within 90\u00a0days of discharge (RR 0.94, 95% CI 0.86, 1.04) among diabetic and non-diabetic subjects was statistically similar. There was an increased risk of in-hospital mortality among those with high blood glucose level at admission (RR 1.45, 95% CI 1.01, 2.09). Among those who were diabetic, the risk of acute renal failure (RR 1.54, 95% CI 1.34, 1.78) was higher than non-diabetics. The risk of respiratory failure, adverse cardiac events, need for additional hospitalization post-discharge and length of hospital stay was similar among diabetics and non-diabetics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Diabetes is not associated with poor survival outcomes in patients with sepsis but is associated with increased risk of acute renal failure. High blood glucose levels, irrespective of the diabetes status, are associated with increased risk of in-hospital mortality. Findings underscore the need for better evaluation of renal function in diabetic patients with concurrent sepsis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-022-00803-2","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T19:02:24Z","timestamp":1646506944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Impact of diabetes mellitus on outcomes of patients with sepsis: an updated systematic review and meta-analysis"],"prefix":"10.1186","volume":"14","author":[{"given":"Li","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"key":"803_CR1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"803_CR2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fendo.2017.00271","volume":"8","author":"LM Frydrych","year":"2017","unstructured":"Frydrych LM, Fattahi F, He K, Ward PA, Delano MJ. Diabetes and sepsis: risk, recurrence, and ruination. Front Endocrinol. 2017;8:271.","journal-title":"Front Endocrinol"},{"key":"803_CR3","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent J-L. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.","journal-title":"Nat Rev Dis Primers"},{"key":"803_CR4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193:259\u201372.","journal-title":"Am J Respir Crit Care Med"},{"key":"803_CR5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/SHK.0000000000000778","volume":"47","author":"SC Trevelin","year":"2017","unstructured":"Trevelin SC, Carlos D, Beretta M, da Silva JS, Cunha FQ. Diabetes mellitus and sepsis: a challenging association. Shock. 2017;47:276\u201387.","journal-title":"Shock"},{"issue":"387","key":"803_CR6","first-page":"1513","volume":"2016","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;2016(387):1513\u201330.","journal-title":"Lancet."},{"key":"803_CR7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10096-011-1337-4","volume":"31","author":"GCKW Koh","year":"2012","unstructured":"Koh GCKW, Peacock SJ, van der Poll T, Wiersinga WJ. The impact of diabetes on the pathogenesis of sepsis. Eur J Clin Microbiol Infect Dis. 2012;31:379\u201388.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"803_CR8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nri2787","volume":"10","author":"A Lehuen","year":"2010","unstructured":"Lehuen A, Diana J, Zaccone P, Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol. 2010;10:501\u201313.","journal-title":"Nat Rev Immunol"},{"key":"803_CR9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4049\/jimmunol.1202907","volume":"191","author":"D Carlos","year":"2013","unstructured":"Carlos D, Spiller F, Souto FO, Trevelin SC, Borges VF, de Freitas A, et al. Histamine h2 receptor signaling in the pathogenesis of sepsis: studies in a murine diabetes model. J Immunol. 2013;191:1373\u201382.","journal-title":"J Immunol"},{"key":"803_CR10","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1007\/s00216-014-8018-y","volume":"406","author":"A Frolov","year":"2014","unstructured":"Frolov A, Bl\u00fcher M, Hoffmann R. Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus. Anal Bioanal Chem. 2014;406:5755\u201363.","journal-title":"Anal Bioanal Chem"},{"key":"803_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-012-0258-7","author":"I Jialal","year":"2012","unstructured":"Jialal I, Kaur H. The role of toll-like receptors in diabetes-induced inflammation: implications for vascular complications. Curr Diab Rep. 2012. https:\/\/doi.org\/10.1007\/s11892-012-0258-7.","journal-title":"Curr Diab Rep"},{"key":"803_CR12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s11658-016-0002-4","volume":"21","author":"Z Sepehri","year":"2016","unstructured":"Sepehri Z, Kiani Z, Nasiri AA, Kohan F. Toll-like receptor 2 and type 2 diabetes. Cell Mol Biol Lett. 2016;21:2.","journal-title":"Cell Mol Biol Lett"},{"key":"803_CR13","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.12659\/MSM.903144","volume":"23","author":"Z Wang","year":"2017","unstructured":"Wang Z, Ren J, Wang G, Liu Q, Guo K, Li J. Association between diabetes mellitus and outcomes of patients with sepsis: a meta-analysis. Med Sci Monit. 2017;23:3546\u201355.","journal-title":"Med Sci Monit"},{"key":"803_CR14","unstructured":"PRISMA. http:\/\/www.prisma-statement.org\/PRISMAStatement\/. Accessed 11 Sep 2021."},{"key":"803_CR15","unstructured":"Wells G, Shea B, O\u2019Connell D, Robertson J, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. p. 21."},{"key":"803_CR16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions: Cochrane book series","author":"JP Higgins","year":"2019","unstructured":"Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions: Cochrane book series. Hoboken: Wiley; 2019. p. 674."},{"key":"803_CR17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11739-020-02507-9","volume":"16","author":"Y Zohar","year":"2021","unstructured":"Zohar Y, Zilberman Itskovich S, Koren S, Zaidenstein R, Marchaim D, Koren R. The association of diabetes and hyperglycemia with sepsis outcomes: a population-based cohort analysis. Intern Emerg Med. 2021;16:719\u201328.","journal-title":"Intern Emerg Med"},{"key":"803_CR18","doi-asserted-by":"crossref","first-page":"e1026","DOI":"10.1097\/CCM.0000000000002590","volume":"45","author":"LA van Vught","year":"2017","unstructured":"van Vught LA, Holman R, de Jonge E, de Keizer NF, van der Poll T. Diabetes is not associated with increased 90-day mortality risk in critically ill patients with sepsis. Crit Care Med. 2017;45:e1026\u201335.","journal-title":"Crit Care Med"},{"key":"803_CR19","doi-asserted-by":"crossref","first-page":"e0170408","DOI":"10.1371\/journal.pone.0170408","volume":"12","author":"H-Y Chao","year":"2017","unstructured":"Chao H-Y, Liu P-H, Lin S-C, Chen C-K, Chen J-C, Chan Y-L, et al. Association of in-hospital mortality and dysglycemia in septic patients. PLoS ONE. 2017;12:e0170408.","journal-title":"PLoS ONE"},{"key":"803_CR20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/0885066619833910","volume":"35","author":"M Sathananthan","year":"2020","unstructured":"Sathananthan M, Sathananthan A, Jeganathan N. Characteristics and outcomes of patients with and without type 2 diabetes mellitus and pulmonary sepsis. J Intensive Care Med. 2020;35:836\u201343.","journal-title":"J Intensive Care Med"},{"key":"803_CR21","doi-asserted-by":"crossref","first-page":"e0229919","DOI":"10.1371\/journal.pone.0229919","volume":"15","author":"S Kushimoto","year":"2020","unstructured":"Kushimoto S, Abe T, Ogura H, Shiraishi A, Saitoh D, Fujishima S, et al. Impact of blood glucose abnormalities on outcomes and disease severity in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis. PLoS ONE. 2020;15:e0229919.","journal-title":"PLoS ONE"},{"key":"803_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.21037\/atm-20-4360","volume":"9","author":"S Lin","year":"2021","unstructured":"Lin S, Ge S, He W, Zeng M. Association between comorbid diabetes mellitus and prognosis of patients with sepsis in the intensive care unit: a retrospective cohort study. Ann Transl Med. 2021;9:22.","journal-title":"Ann Transl Med"},{"key":"803_CR23","doi-asserted-by":"crossref","first-page":"107765","DOI":"10.1016\/j.jdiacomp.2020.107765","volume":"35","author":"K Akinosoglou","year":"2021","unstructured":"Akinosoglou K, Kapsokosta G, Mouktaroudi M, Rovina N, Kaldis V, Stefos A, et al. Diabetes on sepsis outcomes in non-ICU patients: a cohort study and review of the literature. J Diabetes Complications. 2021;35:107765.","journal-title":"J Diabetes Complications"},{"key":"803_CR24","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1097\/00003246-200007000-00001","volume":"28","author":"M Moss","year":"2000","unstructured":"Moss M, Guidot DM, Steinberg KP, Duhon GF, Treece P, Wolken R, et al. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med. 2000;28:2187\u201392.","journal-title":"Crit Care Med"},{"key":"803_CR25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jinf.2008.04.004","volume":"57","author":"AG Moutzouri","year":"2008","unstructured":"Moutzouri AG, Athanassiou GA, Dimitropoulou D, Skoutelis AT, Gogos CA. Severe sepsis and diabetes mellitus have additive effects on red blood cell deformability. J Infect. 2008;57:147\u201351.","journal-title":"J Infect"},{"key":"803_CR26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/CCM.0b013e3181c02726","volume":"38","author":"ME Stegenga","year":"2010","unstructured":"Stegenga ME, Vincent J-L, Vail GM, Xie J, Haney DJ, Williams MD, et al. Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Crit Care Med. 2010;38:539\u201345.","journal-title":"Crit Care Med"},{"key":"803_CR27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.annemergmed.2011.03.052","volume":"58","author":"P Schuetz","year":"2011","unstructured":"Schuetz P, Jones AE, Howell MD, Trzeciak S, Ngo L, Younger JG, et al. Diabetes is not associated with increased mortality in emergency department patients with sepsis. Ann Emerg Med. 2011;58:438\u201344.","journal-title":"Ann Emerg Med"},{"key":"803_CR28","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.4037\/ajcc2011391","volume":"20","author":"Y Yang","year":"2011","unstructured":"Yang Y, Salam Z-HA, Ong BC, Yang KS. Respiratory dysfunction in patients with sepsis: protective effect of diabetes mellitus. Am J Crit Care. 2011;20:e41-47.","journal-title":"Am J Crit Care"},{"key":"803_CR29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.amjmed.2012.03.001","volume":"125","author":"P Schuetz","year":"2012","unstructured":"Schuetz P, Kennedy M, Lucas JM, Howell MD, Aird WC, Yealy DM, et al. Initial management of septic patients with hyperglycemia in the noncritical care inpatient setting. Am J Med. 2012;125:670\u20138.","journal-title":"Am J Med"},{"key":"803_CR30","doi-asserted-by":"crossref","first-page":"e50729","DOI":"10.1371\/journal.pone.0050729","volume":"7","author":"C-W Chang","year":"2012","unstructured":"Chang C-W, Kok VC, Tseng T-C, Horng J-T, Liu C-E. Diabetic patients with severe sepsis admitted to intensive care unit do not fare worse than non-diabetic patients: a nationwide population-based cohort study. PLoS ONE. 2012;7:e50729.","journal-title":"PLoS ONE"},{"key":"803_CR31","doi-asserted-by":"crossref","unstructured":"Al-Dorzi HM, Tamim H, Bouchama A, Kumar A, Arabi YM. Presentation and outcome of diabetic patients admitted with septic shock. In: B23. outcomes, health services and patient-centered research in the intensive care unit. American Thoracic Society; 2012. p. A2552\u2013A2552.","DOI":"10.1164\/ajrccm-conference.2012.185.1_MeetingAbstracts.A2552"},{"key":"803_CR32","doi-asserted-by":"crossref","first-page":"e0127411","DOI":"10.1371\/journal.pone.0127411","volume":"10","author":"M Venot","year":"2015","unstructured":"Venot M, Weis L, Clec\u2019h C, Darmon M, Allaouchiche B, Goldgran-Tol\u00e9dano D, et al. Acute kidney injury in severe sepsis and septic shock in patients with and without diabetes mellitus: a multicenter study. PLoS ONE. 2015;10:e0127411.","journal-title":"PLoS ONE"},{"key":"803_CR33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.diabres.2015.10.008","volume":"110","author":"JM de Miguel-Yanes","year":"2015","unstructured":"de Miguel-Yanes JM, M\u00e9ndez-Bail\u00f3n M, Jim\u00e9nez-Garc\u00eda R, Hern\u00e1ndez-Barrera V, P\u00e9rez-Farin\u00f3s N, L\u00f3pez-de-Andr\u00e9s A. Trends in sepsis incidence and outcomes among people with or without type 2 diabetes mellitus in Spain (2008\u20132012). Diabetes Res Clin Pract. 2015;110:266\u201375.","journal-title":"Diabetes Res Clin Pract"},{"key":"803_CR34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jinf.2014.05.002","volume":"69","author":"Y Kim","year":"2014","unstructured":"Kim Y, Wie S-H, Chang U-I, Kim J, Ki M, Cho YK, et al. Comparison of the clinical characteristics of diabetic and non-diabetic women with community-acquired acute pyelonephritis: a multicenter study. J Infect. 2014;69:244\u201351.","journal-title":"J Infect"},{"key":"803_CR35","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/j.1532-5415.2009.02550.x","volume":"57","author":"DP Kofteridis","year":"2009","unstructured":"Kofteridis DP, Papadimitraki E, Mantadakis E, Maraki S, Papadakis JA, Tzifa G, et al. Effect of diabetes mellitus on the clinical and microbiological features of hospitalized elderly patients with acute pyelonephritis. J Am Geriatr Soc. 2009;57:2125\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"803_CR36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2334-9-94","volume":"9","author":"G Peralta","year":"2009","unstructured":"Peralta G, S\u00e1nchez MB, Roiz MP, Garrido JC, Teira R, Mateos F. Diabetes does not affect outcome in patients with Enterobacteriaceae bacteremia. BMC Infect Dis. 2009;9:94.","journal-title":"BMC Infect Dis"},{"key":"803_CR37","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/diacare.28.4.810","volume":"28","author":"FA McAlister","year":"2005","unstructured":"McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28:810\u20135.","journal-title":"Diabetes Care"},{"key":"803_CR38","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1590\/S0100-879X2006005000143","volume":"40","author":"TC Alba-Loureiro","year":"2007","unstructured":"Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res. 2007;40:1037\u201344.","journal-title":"Braz J Med Biol Res"},{"key":"803_CR39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2337\/diab.39.4.466","volume":"39","author":"M Masuda","year":"1990","unstructured":"Masuda M, Murakami T, Egawa H, Murata K. Decreased fluidity of polymorphonuclear leukocyte membrane in streptozocin-induced diabetic rats. Diabetes. 1990;39:466\u201370.","journal-title":"Diabetes"},{"key":"803_CR40","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.12659\/MSM.896772","volume":"22","author":"Y Cui","year":"2016","unstructured":"Cui Y, Chen W, Chi J, Wang L. Comparison of transcriptome between type 2 diabetes mellitus and impaired fasting glucose. Med Sci Monit. 2016;22:4699\u2013706.","journal-title":"Med Sci Monit"},{"key":"803_CR41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813\u201320.","journal-title":"Nature"},{"key":"803_CR42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000363554","volume":"127","author":"V Vallon","year":"2014","unstructured":"Vallon V. Do tubular changes in the diabetic kidney affect the susceptibility to acute kidney injury? Nephron Clin Pract. 2014;127:133\u20138.","journal-title":"Nephron Clin Pract"},{"key":"803_CR43","doi-asserted-by":"crossref","first-page":"6232909","DOI":"10.1155\/2016\/6232909","volume":"2016","author":"D Patschan","year":"2016","unstructured":"Patschan D, M\u00fcller GA. Acute kidney injury in diabetes mellitus. Int J Nephrol. 2016;2016:6232909.","journal-title":"Int J Nephrol"},{"key":"803_CR44","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jinf.2007.05.177","volume":"55","author":"L Leonidou","year":"2007","unstructured":"Leonidou L, Mouzaki A, Michalaki M, DeLastic AL, Kyriazopoulou V, Bassaris HP, et al. Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. J Infect. 2007;55:340\u20136.","journal-title":"J Infect"},{"key":"803_CR45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1620\/tjem.226.213","volume":"226","author":"EO Jim\u00e9nez-Ib\u00e1\u00f1ez","year":"2012","unstructured":"Jim\u00e9nez-Ib\u00e1\u00f1ez EO, Castillejos-L\u00f3pez M, Hern\u00e1ndez A, Gorocica P, Alvarado-V\u00e1squez N. High mortality associated with hyperglycemia, neutrophilia, and lymphopenia in critically ill patients. Tohoku J Exp Med. 2012;226:213\u201320.","journal-title":"Tohoku J Exp Med"},{"key":"803_CR46","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3748\/wjg.v9.i8.1824","volume":"9","author":"W-K Yu","year":"2003","unstructured":"Yu W-K, Li W-Q, Li N, Li J-S. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol. 2003;9:1824\u20137.","journal-title":"World J Gastroenterol"},{"key":"803_CR47","doi-asserted-by":"crossref","first-page":"E575","DOI":"10.21037\/jtd.2016.05.63","volume":"8","author":"K Nugent","year":"2016","unstructured":"Nugent K, Edriss H, Selvan K. Hyperglycemia and outcomes in patients with sepsis. J Thorac Dis. 2016;8:E575\u20137.","journal-title":"J Thorac Dis"},{"key":"803_CR48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00365513.2019.1613673","volume":"79","author":"C Bellia","year":"2019","unstructured":"Bellia C, Cosma C, Lo Sasso B, Bivona G, Agnello L, Zaninotto M, et al. Glycated albumin as a glycaemic marker in patients with advanced chronic kidney disease and anaemia: a preliminary report. Scand J Clin Lab Invest. 2019;79:293\u20137.","journal-title":"Scand J Clin Lab Invest"},{"key":"803_CR49","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.3390\/jcm9113634","volume":"9","author":"RV Giglio","year":"2020","unstructured":"Giglio RV, Lo Sasso B, Agnello L, Bivona G, Maniscalco R, Ligi D, et al. Recent updates and advances in the use of glycated albumin for the diagnosis and monitoring of diabetes and renal, cerebro- and cardio-metabolic diseases. J Clin Med. 2020;9:3634.","journal-title":"J Clin Med"},{"key":"803_CR50","doi-asserted-by":"crossref","first-page":"030709","DOI":"10.11613\/BM.2017.030709","volume":"27","author":"L Agnello","year":"2017","unstructured":"Agnello L, Bellia C, Lo Sasso B, Pivetti A, Muratore M, Scazzone C, et al. Establishing the upper reference limit of galectin-3 in healthy blood donors. Biochem Med. 2017;27:030709.","journal-title":"Biochem Med"},{"key":"803_CR51","doi-asserted-by":"crossref","first-page":"020901","DOI":"10.11613\/BM.2019.020901","volume":"29","author":"L Agnello","year":"2019","unstructured":"Agnello L, Bellia C, Scazzone C, Bivona G, Iacolino G, Gambino CM, et al. Establishing the 99th percentile for high sensitivity cardiac troponin I in healthy blood donors from Southern Italy. Biochem Med. 2019;29:020901.","journal-title":"Biochem Med"},{"key":"803_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2018.04.021","volume":"58","author":"G Bivona","year":"2018","unstructured":"Bivona G, Agnello L, Bellia C, Lo Sasso B, Ciaccio M. Diagnostic and prognostic value of H-FABP in acute coronary syndrome: still evidence to bring. Clin Biochem. 2018;58:1\u20134.","journal-title":"Clin Biochem"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-022-00803-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-022-00803-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-022-00803-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T19:03:14Z","timestamp":1646506994000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-022-00803-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["803"],"URL":"https:\/\/doi.org\/10.1186\/s13098-022-00803-2","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"21 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}